| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/10/2004 | US20040110839 Compounds and compositions for delivering active agents |
| 06/10/2004 | US20040110833 administering a patient an ester of an alpha-ketoalkanoic acid selected from alpha-ketopropionic acid (pyruvate), alpha-keto-butyrate, alpha-ketopentanoate, alpha-keto-3-methyl-pentanoate etc. to treat cytokine mediated inflammatory conditions |
| 06/10/2004 | US20040110828 for treating, lessening, or ameliorating emesis, anorexia, or chronic or AIDS-related wasting syndrome |
| 06/10/2004 | US20040110827 Has the 3S,4S configuration and is >99.90% over the 3R,4R enantiomer; nervous system disorders; chronic neurodegenerative diseases, CNS poisoning, cognition activators; antiinflammatory agents; autoimmune diseases; side effect reduction |
| 06/10/2004 | US20040110735 Methods of activating receptor using amphiphilic drug-oligomer conjugates |
| 06/10/2004 | US20040110732 Pharmaceutical composition for transdermal or transmucosal administration comprising at least one progestin and/or at least one oestrogen, process for preparing it and uses thereof |
| 06/10/2004 | US20040110730 Using salts of hydrazine and/or (thio)carbonylamino derivatives of hydrazine for conjugation and immobilization of biomolecules; diagnosis |
| 06/10/2004 | US20040110728 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 06/10/2004 | US20040110695 Phospholipid vesicle having exogenous antigen orpolynucleic acid coding for antigen; adapted to be phagocytosed by antigen presenting cells |
| 06/10/2004 | US20040110694 Bioavailability of water insoluble drugs is improved by mixing with polyvinylpyrrolidone carrier; dissolving surfactant and plasticizer/solubilizer in water; spraying solution onto drug/carrier mixture in fluidized bed granulator; extrusion |
| 06/10/2004 | US20040110690 Transporter peptide capable of translocating across biological membrane of pancreatic B-cells, hepatocytes, colon cells, muscle cells and/or lung cells; drug delivery; biochemical conjugation |
| 06/10/2004 | US20040110685 Scatter factor/hepatocyte growth factor antagonist NK4 for the treatment of glioma |
| 06/10/2004 | US20040110678 Novel drug delivery system |
| 06/10/2004 | US20040110661 Rapidly disintegrating tablet comprising an acid-labile active ingredient |
| 06/10/2004 | US20040110659 Reaction of glycol with amine and carbonate to form cabamate for surfactants and detergents |
| 06/10/2004 | US20040110296 biological conjugates used for drug delivery; side effect reduction |
| 06/10/2004 | US20040110250 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 06/10/2004 | US20040110239 Detection to the HER2 receptor by means of biotinilated humanized antibody |
| 06/10/2004 | US20040109920 Coated carotenoid cyclodextrin complexes |
| 06/10/2004 | US20040109902 Dermatological formulations |
| 06/10/2004 | US20040109900 Method for producing a water-alcohol solution and products based thereon |
| 06/10/2004 | US20040109898 Mixture of glycerin as fluid carrier and capsicum plant extract; sexual disorders |
| 06/10/2004 | US20040109897 Mixture of solid phthalic dialdehyde, anticaking agent and dispersant |
| 06/10/2004 | US20040109896 Herpes viruse infections of the eyes; aqueous suspension of acyclovir, vinyl acetate-vinyl alcohol copolymer and nonionic surfactant |
| 06/10/2004 | US20040109893 Drug delivery of bupivacaine |
| 06/10/2004 | US20040109892 Segmented copolyesters as compliant, absorbable coatings and sealants for vascular devices |
| 06/10/2004 | US20040109891 Antidiabetic agents |
| 06/10/2004 | US20040109890 Tablets quickly disintegrated in oral cavity |
| 06/10/2004 | US20040109888 Cyclodextrin-based materials, compositions and uses related thereto |
| 06/10/2004 | US20040109887 Immunogenic proteoliposomes, and uses thereof |
| 06/10/2004 | US20040109871 Gene, immunogen transfer ; induction mucous membrane immunity; polynucleotide sequences ; bactericides, viricides, fungicides, parasirtici des, anticancer agents |
| 06/10/2004 | US20040109867 Prodrugs of CC-1065 analogs |
| 06/10/2004 | US20040109866 Immonotherapy complex containing antigen, antibodies, epitopes; binding to receptors |
| 06/10/2004 | US20040109863 Methods of therapy and diagnosis using targeting of cells that express Ly-9 |
| 06/10/2004 | US20040109862 Methods of therapy and diagnosis using targeting of cells that express Ly-9 |
| 06/10/2004 | US20040109861 Isolated protein complexes; screening analyzing; human t-cell leukemia virus |
| 06/10/2004 | US20040109853 Biological active coating components, coatings, and coated surfaces |
| 06/10/2004 | US20040109843 Pharmaceutical composition containing decoy and use of the same |
| 06/10/2004 | US20040109841 absence of a linker minimizes structural complexity of the derivative and simplifies synthesis of the derivative |
| 06/10/2004 | US20040109838 Compositions containing copolymers based on acryloyldimethyl aminoethylsulfonic acid and synergistic additives |
| 06/10/2004 | US20040109836 comprising comb copolymers based on acryloyldimethyltaurine |
| 06/10/2004 | US20040109828 unique crystalline agglomerates of a first material and a solid binder which are free-flowing, sufficiently bulky and sufficiently stable to be handled, metered and delivered, even in extremely small doses |
| 06/10/2004 | US20040109825 Elevated temperature storage stable fluid compositions of a delayed-type hypersensitivity (DTH) inducer, e.g., 1-Chloro-2,4 Dinitrobenzene (DNCB) |
| 06/10/2004 | US20040109823 Flexible and/or elastic brachytherapy seed or strand |
| 06/10/2004 | CA2547531A1 Buoyant polymer particles for delivery of therapeutic agents to the central nervous system |
| 06/10/2004 | CA2518906A1 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof |
| 06/10/2004 | CA2509429A1 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 06/10/2004 | CA2507687A1 Nanoparticle conjugates and method of production thereof |
| 06/10/2004 | CA2507460A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/10/2004 | CA2507356A1 High concentration formulations of opioids and opioid derivatives |
| 06/10/2004 | CA2507045A1 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
| 06/10/2004 | CA2507018A1 Materials and methods for preventing and treating microbe-mediated epithelial disorders |
| 06/10/2004 | CA2506526A1 Broad spectrum anti-viral therapeutics and prophylaxis |
| 06/10/2004 | CA2505524A1 Novel use of erythropoietin in heart diseases |
| 06/10/2004 | CA2504287A1 Natriuretic compounds, conjugates, and uses thereof |
| 06/09/2004 | EP1426382A1 Antiviral human serum albumin |
| 06/09/2004 | EP1426380A1 Association compound of trehalose or maltitol with metal ion compound |
| 06/09/2004 | EP1426361A1 Novel composition containing a bi-cyclic compound and a glyceride |
| 06/09/2004 | EP1426062A2 Radiolabeled annexins |
| 06/09/2004 | EP1426061A2 Cosmetic composition containing electrically charged particles |
| 06/09/2004 | EP1426058A2 Liquid interferon-beta formulations |
| 06/09/2004 | EP1426055A1 Targeted protein degradation vehicles (tpdvs), nucleic acid constructs encoding them and their use |
| 06/09/2004 | EP1426049A1 Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease |
| 06/09/2004 | EP1426044A1 Use of esters of L-carnitine or alkanoyl L-carnitines as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 06/09/2004 | EP1426029A1 Emulsion compositions |
| 06/09/2004 | EP1425408A2 Chemo-enzymatic synthesis of sialylated oligosaccharides |
| 06/09/2004 | EP1425390A2 Materials and methods to promote repair of nerve tissue |
| 06/09/2004 | EP1425381A2 Emu-based formulations for wound treatment related application information |
| 06/09/2004 | EP1425310A2 Water soluble, randomly substituted partial n-, partial o-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof |
| 06/09/2004 | EP1425308A2 Polysaccharidic esters of retinoic acid |
| 06/09/2004 | EP1425306A2 Nanoparticles comprising biologically active tnf which is immobilised on the same |
| 06/09/2004 | EP1425304A2 G-csf conjugates |
| 06/09/2004 | EP1425044A1 Topical composition, topical composition precursor, and methods for manufacturing and using |
| 06/09/2004 | EP1425041A2 Methods for sterilizing preparations of monoclonal immunoglobulins |
| 06/09/2004 | EP1425028A2 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 06/09/2004 | EP1425019A1 Pharmaceutical composition |
| 06/09/2004 | EP1425005A1 Pharmaceutical compostion comprising lumiracoxib |
| 06/09/2004 | EP1424998A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/09/2004 | EP1424997A1 Amino acid modulated extended release dosage form |
| 06/09/2004 | EP1424994A1 Preparation of sustained release pharmaceutical composition |
| 06/09/2004 | EP1424971A1 Eustachian tube stent |
| 06/09/2004 | EP1424957A2 Microfabricated nanopore device for sustained release of therapeutic agent |
| 06/09/2004 | EP1326631B1 Botulinumtoxin for treating endocrine disorders |
| 06/09/2004 | EP1180102B1 Mutual prodrugs of amlodipine and atorvastatin |
| 06/09/2004 | EP1148875B1 Methods and compositions to enhance white blood cell count |
| 06/09/2004 | EP1061954B1 Poly(ethylene glycol) derivatives with proximal reactive groups |
| 06/09/2004 | EP1043978B1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 06/09/2004 | EP1005339A4 Carotenoid formulation |
| 06/09/2004 | EP0934081B1 Antineoplastic conjugates of albumin |
| 06/09/2004 | DE20220902U1 Neuer Filmüberzug New film coating |
| 06/09/2004 | DE10255415A1 Dermale Applikation von Flupirtin Dermal application of flupirtine |
| 06/09/2004 | DE10255195A1 Micellare wasserlösliche Konzentrate Micellar water-soluble concentrates |
| 06/09/2004 | CN1503816A Agent for the prevention and treatment of sexually transmitted diseases-1 |
| 06/09/2004 | CN1503680A Ascorbic a cid analogs for metalloradiopharmaceuticals |
| 06/09/2004 | CN1503679A Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
| 06/09/2004 | CN1503675A Telithromycin suspension with a masked taste |
| 06/09/2004 | CN1503663A Film coating |
| 06/09/2004 | CN1503662A Pharmaceutical preparation |
| 06/09/2004 | CN1503661A Control of process humidify to produce large porous particles |
| 06/09/2004 | CN1503658A Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier |